[Drug treatment of male infertility].
García Díez
L C
LC
Servicio de Endocrinología, Facultad de Medicina, Hospital Clínico Universitario, Salamanca.
Corrales Hernández
J J
JJ
Terroba
C
C
D000728:Androgens / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D004873:Ergolines / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006062:Gonadotropins / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007248:Infertility, Male / Q000175:diagnosis / Q000188:drug therapy*; D007610:Kallikreins / Q000627:therapeutic use; D008297:Male; D010431:Pentoxifylline / Q000627:therapeutic use; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D013738:Testolactone / Q000627:therapeutic use; D013739:Testosterone / Q000627:therapeutic use
D000728:Androgens; D004873:Ergolines; D004965:Estrogen Antagonists; D005938:Glucocorticoids; D006062:Gonadotropins; D007166:Immunosuppressive Agents; D011448:Prostaglandin Antagonists; D007987:Gonadotropin-Releasing Hormone; D001971:Bromocriptine; D013739:Testosterone; D013738:Testolactone; D007610:Kallikreins; D010431:Pentoxifylline
Tratamiento médico de la infertilidad masculina.